Conduent Leverages GenAI to Transform Reportable Event Detection and Establish New FDA Compliance Standards
New GenAI Solution Launch: Conduent has introduced a GenAI-powered reportable event detection solution designed to enhance the identification of events for Pharma and Life Sciences companies, ensuring compliance with FDA regulations.
Improved Efficiency and Compliance: The solution automates the review of nearly 100% of customer interactions across various channels, improving the speed, accuracy, and consistency of identifying reportable events, thus minimizing the risk of penalties.
Real-World Applications: Examples of reportable events include patient reports of adverse reactions, caregiver complaints about product issues, and customer inquiries regarding dosage instructions, all of which can now be efficiently captured and classified.
Integration with Microsoft Azure OpenAI: This new tool leverages Microsoft Azure OpenAI to combine AI capabilities with compliance expertise, ultimately helping clients save time and costs while enhancing patient safety and product quality.
Get Free Real-Time Notifications for Any Stock
Analyst Views on CNDT

No data
About CNDT
About the author

Conduent Appoints New CEO Harsha V. Agadi, Board Chair Transition
- Leadership Change: Conduent has appointed Harsha V. Agadi as CEO effective immediately, while he steps down as Chairman, with Margarita Paláu-Hernández taking over as independent Chair, demonstrating the company's swift decision-making in executive transitions.
- Former CEO Departure: Cliff Skelton will resign from his roles as CEO, President, and Board member, marking a strategic shift as the company faces revenue declines and market challenges, which may impact future operational directions.
- Board Structure Adjustment: The appointment of new Chair Margarita Paláu-Hernández aims to enhance the board's independence and governance capabilities, thereby improving decision-making efficiency in a complex market environment.
- Market Reaction Expectations: This leadership transition may have a short-term impact on Conduent's stock price, particularly as the company seeks to stabilize revenue amidst AI-driven expansion and government policy challenges.

Conduent Appoints Harsha Agadi as CEO, Aiming for Growth Acceleration
- Leadership Transition: Conduent has appointed Harsha V. Agadi as CEO while Margarita Paláu-Hernández takes over as independent Chair of the Board, aiming to leverage Agadi's leadership experience for future growth.
- Experienced CEO: Agadi brings over 35 years of executive leadership and corporate governance experience, having served as CEO for multiple Fortune 50 companies, which is expected to enhance Conduent's competitive position in the market.
- Clear Strategic Goals: Agadi emphasized a focus on accelerating company growth and delivering long-term value for clients, shareholders, and employees, reflecting Conduent's ambition in the digital business solutions sector.
- Board Confidence: New Chair Paláu-Hernández expressed confidence in Agadi's leadership, highlighting the Board's support and trust in the company's future development, indicating stability in the governance structure.









